On this page
How do you correct or withdraw an FDA promotional submission?
Identify the original purpose, format, tracking reference and exact affected material. Missing or rejected promotional material, missing annotations, substantive revisions and withdrawal are different events. For a 2253 correction, the guidance distinguishes eCTD amendments from resubmission of the entire paper or other non-eCTD package. A withdrawal request states the actual intent; it does not undo completed dissemination or erase reporting obligations.
Before you begin
Amendment and withdrawal tasks described in the April 2022 promotional-submissions guidance. The appropriate route depends on the original submission purpose and whether material is missing, revised or no longer intended for review/use.
What you will prepare: A narrowly identified corrective or withdrawal communication linked to the correct original submission.
Sections covered in this guide (2)
Identify what actually went wrong or changed
Under IV.F, first identify the original submission purpose and format. For an eCTD 2253 submission, missing or rejected promotional material or an incorrect document is handled through the applicable amendment. For a paper or other non-eCTD 2253 submission with missing or rejected material or an incorrect document, the guidance says to resubmit the entire 2253 submission. This historical correction distinction does not authorize a new submission in an otherwise unsupported format. Missing annotations or references can belong to the reference-document task described in IV.J. A revised piece after comments is another workflow. Record the original purpose, tracking number, promised file list, actual submitted files and current intent. Do not use “amendment” as a generic label for every new document.
Describe the correction precisely
Name the omitted or incorrect file and its material ID. Supply the correct artifact with the original submission relationship and explain whether any substantive content changed. Check that the corrected file opens and that its annotations point to the intended sources. Have the publisher apply version-appropriate lifecycle handling; changing a local filename does not repair an agency submission.
Define exactly what is being withdrawn
For a withdrawal request under IV.G, identify the affected review request and materials and explain the actual intent. Distinguish withdrawing a voluntary request from deciding not to use accelerated-approval promotional material. Do not imply that withdrawal erases a prior submission, retracts completed dissemination or cancels a reporting obligation. Retain unaffected pieces and their review status explicitly.
Fictional example: one missing brochure
A manifest listed two brochures but the transmission contained only one. Supply the missing brochure through the appropriate amendment workflow and link the original record. If the brochure instead exists in the submission but only its annotations are absent, reassess the reference-document route. If the business cancels the campaign, clarify whether the whole request or only one piece is withdrawn before composing the letter.
Separate the missing file from the changed business decision
Compare the promised manifest with the actual transmitted package before selecting the corrective task. A local folder can contain a file that was never transmitted; a transmitted file can be unreadable; and a newer draft can be a substantive revision rather than the omitted original.
| Finding | Original context | Preparation consequence |
|---|---|---|
| Entire promotional piece missing | Advisory request or accelerated presubmission | Assess the amendment with the appropriate companion artifacts |
| Promotional material missing/rejected or incorrect document | eCTD 2253 submission | Submit the applicable amendment identifying the original relationship |
| Missing/rejected material or incorrect document | Paper or other non-eCTD 2253 submission | Guidance IV.F describes resubmitting the entire 2253 submission |
| Clean piece present, annotations missing | Previous promotional review submission | Assess reference-document correspondence under IV.J |
| Draft changed after FDA comments | Further draft review intended | Assess resubmission under IV.D and explain changes |
| Review request no longer wanted | Voluntary request | State the exact scope and actual use intent in withdrawal correspondence |
| Required accelerated materials no longer intended for use | Accelerated-approval presubmission | Withdrawal is described for material the firm does not plan to disseminate |
The historical paper/non-eCTD correction distinction is not permission to initiate a new submission in an otherwise unsupported format. Establish the original package and today's applicable submission instructions. Likewise, do not copy legacy eCTD lifecycle operators into a v4.0 package; the publishing owner must implement the supported relationship for the actual version.
Fictional file-recovery exercise: the original eCTD manifest lists videos A and B, but B was rejected because it would not play. The team prepares a new B with altered claims. Before calling it a missing-file correction, identify the intended original material and the substantive difference. Resolve which artifact is actually being supplied and whether another route is needed. A correction letter should not conceal a new claim under an old material identity.
For withdrawal, identify the original submission date or tracking reference and each affected material. Guidance IV.G describes correspondence without submitted materials. If only one piece is affected, make the limited scope explicit and retain the status of the others. When accelerated-approval material is still intended for use without waiting for comments, assess the general-correspondence route described in IV.E and the actual product conditions instead of treating withdrawal as release permission.
After the corrective transmission, verify the actual receipt and usable artifact, not just the export folder. Retain the original record and the explanation of what changed. Use the missing-reference guide when support rather than the clean piece is missing, and the planning guide when the new facts change the submission purpose.
Your preparation checklist
0/3 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Is the same correction used for eCTD and non-eCTD 2253 submissions?
No. Guidance IV.F describes an amendment for the applicable eCTD missing or rejected materials, while an incorrect document or missing/rejected material in a paper or other non-eCTD 2253 package calls for resubmitting the entire package. Verify the original format and current submission instructions before preparing the correction.
Are missing annotated references handled like an entirely missing promotional piece?
The guidance distinguishes them. Missing annotated material, labeling or references can use the IV.J reference-document task when the clean piece was present. An entirely omitted promotional piece belongs in the missing-material assessment. Compare the actual transmitted files with the original manifest instead of classifying from a filename.
Does withdrawal erase a previously disseminated advertisement or its reporting obligations?
No. State the actual use history and scope of the request. Withdrawal correspondence cannot change past dissemination into non-use or make a required report disappear. The guidance distinguishes withdrawal of voluntary review from accelerated-approval material that the firm no longer intends to disseminate.
Can changed claims be silently supplied as the previously missing file?
No. Compare the proposed replacement with the original intended material and disclose substantive differences. Determine the correct route for the actual event and preserve material identity and version history. Calling a new presentation a missing-file correction does not establish that the earlier review or timing applies to it.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Guidance
FDA: Submissions of Promotional Labeling and Advertising ↗April 2022 final, Revision 1; IV.A–J, VI.E–H and VII. PDF production/PRA update April 2023 does not change the cover revision. Its legacy backbone syntax is not an eCTD v4 implementation guide. Checked September 22, 2026.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 1.15.1.8. A heading identifies placement, not mandatory applicability.